PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
451,000
+8,000 (1.81%)
May 30, 2025, 3:30 PM KST
235.07%
Market Cap 4.60T
Revenue (ttm) 392.31B
Net Income (ttm) 110.97B
Shares Out 10.39M
EPS (ttm) 10,648.93
PE Ratio 41.60
Forward PE 30.91
Dividend 1,100.00 (0.25%)
Ex-Dividend Date Dec 27, 2024
Volume 59,603
Average Volume 71,080
Open 440,000
Previous Close 443,000
Day's Range 438,500 - 451,500
52-Week Range 121,300 - 454,500
Beta 0.53
RSI 66.56
Earnings Date May 9, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 409
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.